PEOPLE

Robin Collingwood, MD

Clinical Assistant Professor of Pathology and Laboratory Medicine
Perelman School of Medicine at the University of Pennsylvania

Contact Information6 Founders Building
Hospital of the University of Pennsylvania

Philadelphia, PA, 19104-4283

Specialty Division

Anatomic Pathology

Education

MD Michican State University - College of Human Medicine, 2011

Specialty Certification

Postgraduate Training

Anatomic Pathology, University of Alabama at Birmingham, 2014-2018
GI Pathology - Fellow/Instructor, University of Alabama at Birmingham, 2018-2019

Awards and Honors

Memberships and Professional Organizations

Web Links


Selected Publications

Second Opinion Expert Pathology Review in Bladder Cancer: Implications for Patient Care.

Gordetsky J, Collingwood R, Lai WS, Del Carmen Rodriquez Pena M, Rais-Bahrami S., Int J Surg Pathol 26(1): 12-17, 2018

Five-year real world outcomes of GeoForm ring implantation in patients with ischemic mitral regurgitation.

Timek TA, Hooker RL, Collingwood R, Davis AT, Alguire CT, Willekes CL, Murphy ET, Heiser JC, Patzelt LH., J Thorac Cardiovasc Surgery. 148(5): 1951-6, 2014

Comparison Between Three-Dimensional Angiographic Reconstruction and Intravascular Ultrasound Imaging For The Measurement of Intracoronary Cross-Sectional Luminal Dimensions.

Collingwood R, Bermudez E, Fischell T., Journal of Interventional Cardiology 22(3): 277-281, 2009

Increased Expression of eNOS by Endeavor, Zotarolimus Eluting Stents Compared to Other DES in Porcine Coronary Artery Implants.

Haraguchi G, Pruitt S, Brodeur A, Collingwood R, Carter A, Melder RJ, Wilcox JN., The American Journal of Cardiology 98(Suppl 8): 32M, 2006

Experimental Efficacy of a Polymeric Everolimus Eluting Cobalt Chromium Stent.

Carter A, Brodeur A, Collingwood R, Ross S, Gibson L, Wang C, Haller S, Coleman L, Virmani R., Catheterization and Cardiovascular Interventions. 68(1): 97-103, 2006

The Effects of a Diffusion Barrier on the Elution Characteristics of ABT-578 via a Phosphorylcholine Matrix.

Carter AJ, Brodeur A, Hasting E, Gibson L, Collingwood R, Ross S, Johnson M, Melder RJ., The American Journal of Cardiology 47(4): Suppl B: 3B, 2006

Experimental Feasibility and Efficacy of a Novel Modular Segmented Stent with In-situ Programmable length and Drug Elution from a Biodegradable Polymer Coating.

Carter AJ, Gibson L, Haller S, Brodeur A, Collingwood R, Ross S, Marco P, Chronos N, Tio F, Robinson K., The American Journal of Cardiology 96(Suppl 7A): 7H, 2005

Dose Response Effects of a Novel Slow-release Polymeric ABT-578 Eluting Stent.

Carter AJ, Brodeur A, Hasting E, Gibson L, Collingwood R, Ross S, Caceres A, Jones R Johnson M, Udipi K, Melder RJ, Virmani R, Wilcox JN., Circulation 112(7): 2304, 2005

Stent Based ABT-578 Reduces Neointimal Formation in the Porcine Coronary Model.

Collingwood R, Gibson L, Sedlik S, Virmani R, Carter A., Catheterization and Cardiovascular Interventions 65(2): 227-232, 2005

Persistent Relative Low Shear Within Sirolimus-Eluting Stents at 30 days in the Porcine Coronary Model: A Potential Physiological Stimulus for Late Neointimal Formation.

Carter AJ, Wei W, Collingwood R, Gibson L, Tio F., Angioplasty Summit 2005 TCT Asia Pacific, Seoul, Korea, 2005